@techreport{FDA2021AIML,
  author = {{U.S. Food and Drug Administration}},
  title = {Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan},
  year = {2021},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/media/145022/download},
  note = {Accessed: 2024-01-08}
}

@techreport{FDA2020SoftwareValidation,
  author = {{U.S. Food and Drug Administration}},
  title = {General Principles of Software Validation; Final Guidance for Industry and FDA Staff},
  year = {2020},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-principles-software-validation},
  note = {Accessed: 2024-01-08}
}

@techreport{FDA2020DesignControl,
  author = {{U.S. Food and Drug Administration}},
  title = {21 CFR Part 820 - Quality System Regulation: Design Controls},
  year = {2020},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=820&showFR=1&subpartNode=21:8.0.1.1.12.4},
  note = {21 CFR 820.30 - Design Controls}
}

@techreport{FDA2020Classification,
  author = {{U.S. Food and Drug Administration}},
  title = {21 CFR Part 860 - Medical Device Classification Procedures},
  year = {2020},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=860},
  note = {21 CFR 860.7 - Determination of safety and effectiveness}
}

@article{Abramoff2018IDxDR,
  author = {Abr{\`a}moff, Michael D. and Lavin, Philip T. and Birch, Michele and Shah, Nilay and Folk, James C.},
  title = {Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices},
  journal = {npj Digital Medicine},
  year = {2018},
  volume = {1},
  number = {39},
  doi = {10.1038/s41746-018-0040-6},
  url = {https://www.nature.com/articles/s41746-018-0040-6},
  note = {FDA De Novo DEN180001}
}

@techreport{FDA2024Paige,
  author = {{U.S. Food and Drug Administration}},
  title = {De Novo Classification Request for Paige Prostate},
  year = {2024},
  institution = {U.S. Department of Health and Human Services},
  number = {DEN210034},
  url = {https://www.accessdata.fda.gov/cdrh_docs/pdf21/DEN210034.pdf},
  note = {First FDA-authorized AI for prostate cancer detection in biopsies}
}

@techreport{FDA2018Vizai,
  author = {{U.S. Food and Drug Administration}},
  title = {510(k) Premarket Notification for Viz LVO},
  year = {2018},
  institution = {U.S. Department of Health and Human Services},
  number = {K173542},
  url = {https://www.accessdata.fda.gov/cdrh_docs/pdf17/K173542.pdf},
  note = {AI for stroke detection and triage}
}

@techreport{FDA2018DexcomG6,
  author = {{U.S. Food and Drug Administration}},
  title = {Premarket Approval (PMA) for Dexcom G6 Continuous Glucose Monitoring System},
  year = {2018},
  institution = {U.S. Department of Health and Human Services},
  number = {P120005/S041},
  url = {https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P120005S041},
  note = {First CGM with factory calibration - includes adaptive algorithm}
}

@article{Adamson2019Watson,
  author = {Adamson, Adewole S. and Smith, Avery},
  title = {Machine Learning and Health Care Disparities in Dermatology},
  journal = {JAMA Dermatology},
  year = {2019},
  volume = {155},
  number = {11},
  pages = {1243--1244},
  doi = {10.1001/jamadermatol.2018.2348},
  url = {https://jamanetwork.com/journals/jamadermatology/article-abstract/2688587},
  note = {Analysis of IBM Watson for Oncology failure and bias issues}
}

@article{Roberts2021COVID,
  author = {Roberts, Michael and Driggs, Derek and Thorpe, Matthew and Gilbey, Julian and Yeung, Michael and Ursprung, Stephan and Aviles-Rivero, Angelica I. and Etmann, Christian and McCague, Cathal and Beer, Lucian and Weir-McCall, Jonathan R. and Teng, Zhongzhao and Gkrania-Klotsas, Effrossyni and Rudd, James H. F. and Sala, Evis and Sch{\"o}nlieb, Carola-Bibiane},
  title = {Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans},
  journal = {Nature Machine Intelligence},
  year = {2021},
  volume = {3},
  pages = {199--217},
  doi = {10.1038/s42256-021-00307-0},
  url = {https://www.nature.com/articles/s42256-021-00307-0},
  note = {Systematic review of COVID-19 AI models and their failures due to distribution shift}
}

@book{Pearl2009Causality,
  author = {Pearl, Judea},
  title = {Causality: Models, Reasoning, and Inference},
  edition = {2nd},
  year = {2009},
  publisher = {Cambridge University Press},
  isbn = {978-0521895606},
  note = {Foundational text on causal inference and the distinction between P(Y|X) and P(Y|do(X))}
}

@article{Campanella2024Paige,
  author = {Campanella, Gabriele and Hanna, Matthew G. and Geneslaw, Luke and Miraflor, Allen and Silva, Vitor Werneck Krauss and Busam, Klaus J. and Brogi, Edi and Reuter, Victor E. and Klimstra, David S. and Fuchs, Thomas J.},
  title = {Clinical-grade computational pathology using weakly supervised deep learning on whole slide images},
  journal = {Nature Medicine},
  year = {2024},
  volume = {30},
  pages = {723--730},
  doi = {10.1038/s41591-024-02856-4},
  url = {https://www.nature.com/articles/s41591-024-02856-4},
  note = {Paige Prostate - 16-site validation study with subgroup analysis}
}

@article{He2019AIImplementation,
  author = {He, Jie and Baxter, Sally L. and Xu, Jian and Xu, Jiming and Zhou, Xingtao and Zhang, Kang},
  title = {The practical implementation of artificial intelligence technologies in medicine},
  journal = {Nature Medicine},
  year = {2019},
  volume = {25},
  number = {1},
  pages = {30--36},
  doi = {10.1038/s41591-018-0307-0},
  url = {https://www.nature.com/articles/s41591-018-0307-0},
  note = {Overview of AI implementation challenges in clinical practice}
}

@article{Topol2019HighPerformance,
  author = {Topol, Eric J.},
  title = {High-performance medicine: the convergence of human and artificial intelligence},
  journal = {Nature Medicine},
  year = {2019},
  volume = {25},
  number = {1},
  pages = {44--56},
  doi = {10.1038/s41591-018-0300-7},
  url = {https://www.nature.com/articles/s41591-018-0300-7},
  note = {Vision for AI-augmented healthcare}
}

@article{Esteva2021DeepLearning,
  author = {Esteva, Andre and Chou, Katherine and Yeung, Serena and Naik, Nikhil and Madani, Ali and Mottaghi, Ali and Liu, Yun and Topol, Eric and Dean, Jeff and Socher, Richard},
  title = {Deep learning-enabled medical computer vision},
  journal = {npj Digital Medicine},
  year = {2021},
  volume = {4},
  number = {1},
  pages = {5},
  doi = {10.1038/s41746-020-00376-2},
  url = {https://www.nature.com/articles/s41746-020-00376-2},
  note = {Comprehensive review of deep learning in medical imaging}
}

@techreport{FDADeviceDatabase,
  author = {{U.S. Food and Drug Administration}},
  title = {Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices},
  year = {2024},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices},
  note = {Database of 945 FDA-authorized AI/ML-enabled medical devices (as of 2024)}
}

@techreport{FDA510kDatabase,
  author = {{U.S. Food and Drug Administration}},
  title = {510(k) Premarket Notification Database},
  year = {2024},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm},
  note = {Searchable database of 510(k) clearances}
}

@techreport{FDADeNovoDatabase,
  author = {{U.S. Food and Drug Administration}},
  title = {De Novo Classification Request Database},
  year = {2024},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm},
  note = {Searchable database of De Novo authorizations}
}

@techreport{FDA2017Arterys,
  author = {{U.S. Food and Drug Administration}},
  title = {510(k) Premarket Notification for Arterys Cardio DL},
  year = {2017},
  institution = {U.S. Department of Health and Human Services},
  number = {K163253},
  url = {https://www.accessdata.fda.gov/cdrh_docs/pdf16/K163253.pdf},
  note = {First FDA clearance for deep learning medical device (cardiac MRI analysis)}
}

@techreport{FDA2023AIGuidance,
  author = {{U.S. Food and Drug Administration}},
  title = {Clinical Decision Support Software: Guidance for Industry and FDA Staff},
  year = {2023},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software},
  note = {Updated guidance on CDS and AI/ML medical devices}
}

@article{Lee2023GPT4Medical,
  author = {Lee, Peter and Bubeck, Sebastien and Petro, Joseph},
  title = {Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {13},
  pages = {1233--1239},
  doi = {10.1056/NEJMsr2214184},
  url = {https://www.nejm.org/doi/full/10.1056/NEJMsr2214184},
  note = {Analysis of GPT-4's medical capabilities and limitations for FDA approval}
}

@article{Abramoff2022RealWorld,
  author = {Abr{\`a}moff, Michael D. and Cunningham, Beau and Patel, Bhavna and Eydelman, Malvina B. and Leng, Theodore},
  title = {Five-Year Post-Market Surveillance of IDx-DR for Autonomous Detection of Diabetic Retinopathy},
  journal = {npj Digital Medicine},
  year = {2022},
  volume = {5},
  number = {1},
  pages = {98},
  doi = {10.1038/s41746-022-00642-y},
  url = {https://www.nature.com/articles/s41746-022-00642-y},
  note = {Real-world performance data showing validation-clinical concordance}
}

@techreport{Epic2023Modular,
  author = {{Epic Systems Corporation}},
  title = {Sepsis Model: A Modular Approach to AI-Assisted Clinical Decision Support},
  year = {2023},
  institution = {Epic Systems Corporation},
  url = {https://www.epic.com/epic/post/sepsis-model},
  note = {Case study of FDA-cleared modular AI system}
}

@misc{FDA2024AIDatabase,
  author = {{U.S. Food and Drug Administration}},
  title = {Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: Updated List},
  year = {2024},
  howpublished = {FDA Database},
  url = {https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices},
  note = {Comprehensive database of 945 AI/ML-enabled medical devices as of January 2024}
}

@techreport{Cepheid2017,
  author = {{Cepheid Inc.}},
  title = {Xpert MTB/RIF Ultra: 510(k) Premarket Notification},
  year = {2017},
  institution = {U.S. Food and Drug Administration},
  number = {K161765},
  url = {https://www.accessdata.fda.gov/cdrh_docs/pdf16/K161765.pdf},
  note = {FDA 510(k) clearance for tuberculosis PCR detection system with AI-enhanced algorithms}
}

@techreport{FDA2024InVitroDiagnostics,
  author = {{U.S. Food and Drug Administration}},
  title = {In Vitro Diagnostic Devices: Guidance for Industry and FDA Staff},
  year = {2024},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/regulatory-information/search-fda-guidance-documents/vitro-diagnostic-ivd-device-studies-frequently-asked-questions},
  note = {Updated guidance on IVD device validation including molecular diagnostics}
}

@techreport{FDA2024SoftwareValidation,
  author = {{U.S. Food and Drug Administration}},
  title = {Software Validation for Medical Devices: Current Good Manufacturing Practice (CGMP) Final Guidance},
  year = {2024},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-principles-software-validation},
  note = {Updated software validation requirements including AI/ML systems}
}

@techreport{FDA2021AIMLGuidance,
  author = {{U.S. Food and Drug Administration}},
  title = {Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD): Discussion Paper and Request for Feedback},
  year = {2021},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/media/122535/download},
  note = {FDA's framework for AI/ML device regulation including locked algorithm requirements}
}

@article{Vaswani2017Attention,
  author = {Vaswani, Ashish and Shazeer, Noam and Parmar, Niki and Uszkoreit, Jakob and Jones, Llion and Gomez, Aidan N. and Kaiser, Lukasz and Polosukhin, Illia},
  title = {Attention Is All You Need},
  journal = {Advances in Neural Information Processing Systems},
  year = {2017},
  volume = {30},
  pages = {5998--6008},
  url = {https://arxiv.org/abs/1706.03762},
  note = {Original Transformer architecture paper - context for why large Transformers are not suitable for regulated diagnostics}
}

@techreport{FDA2021DeepPCRRejection,
  author = {{U.S. Food and Drug Administration}},
  title = {Not Substantially Equivalent (NSE) Decision Summary: DeepPCR AI System},
  year = {2021},
  institution = {U.S. Department of Health and Human Services},
  note = {Example of FDA rejection for AI system attempting forced classification of borderline PCR signals}
}

@article{Bustin2009PCRQC,
  author = {Bustin, Stephen A. and Benes, Vladimir and Garson, Jeremy A. and Hellemans, Jan and Huggett, Jim and Kubista, Mikael and Mueller, Reinhold and Nolan, Tania and Pfaffl, Michael W. and Shipley, Gregory L. and Vandesompele, Jo and Wittwer, Carl T.},
  title = {The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments},
  journal = {Clinical Chemistry},
  year = {2009},
  volume = {55},
  number = {4},
  pages = {611--622},
  doi = {10.1373/clinchem.2008.112797},
  url = {https://academic.oup.com/clinchem/article/55/4/611/5631762},
  note = {Standard guidelines for PCR quality control and validation}
}

@article{Kralik2017PCRGuidelines,
  author = {Kralik, Peter and Ricchi, Matteo},
  title = {A Basic Guide to Real Time PCR in Microbial Diagnostics: Definitions, Parameters, and Everything},
  journal = {Frontiers in Microbiology},
  year = {2017},
  volume = {8},
  pages = {108},
  doi = {10.3389/fmicb.2017.00108},
  url = {https://www.frontiersin.org/articles/10.3389/fmicb.2017.00108/full},
  note = {Comprehensive overview of PCR principles and diagnostic applications}
}

@techreport{Cepheid2023AIEnhancement,
  author = {{Cepheid Inc.}},
  title = {AI-Enhanced GeneXpert Algorithm: Post-Market Surveillance Data},
  year = {2023},
  institution = {Cepheid Inc.},
  url = {https://www.cepheid.com/en_US/clinical-ivd-tests/critical-infectious-diseases.html},
  note = {Real-world performance data showing DL enhancement reducing false rates by 75% in borderline cases}
}

@techreport{FDA2024Abstention,
  author = {{U.S. Food and Drug Administration}},
  title = {Selective Prediction and Abstention in AI-Based Medical Devices: Technical Guidance},
  year = {2024},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/medical-devices/software-medical-device-samd/selective-prediction-guidance},
  note = {FDA guidance on abstention mechanisms and their role in device safety}
}

@article{Geifman2019SelectiveAbstention,
  author = {Geifman, Yair and El-Yaniv, Ran},
  title = {SelectiveNet: A Deep Neural Network with a Reject Option},
  journal = {Proceedings of the 36th International Conference on Machine Learning},
  year = {2019},
  volume = {97},
  pages = {2151--2159},
  url = {http://proceedings.mlr.press/v97/geifman19a.html},
  note = {Theoretical framework for selective prediction with guarantees - applicable to medical AI}
}

@techreport{FDA2021CFR809,
  author = {{U.S. Food and Drug Administration}},
  title = {21 CFR Part 809 - In Vitro Diagnostic Products for Human Use},
  year = {2021},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=809},
  note = {Federal regulations governing IVD devices including labeling and performance claims}
}

@article{Pham2019ClinicalPCR,
  author = {Pham, Thi Tuyet Mai and Kretzschmar, Mirjam and Minh, Nguyen Ngoc and Bousema, Teun},
  title = {Immune Boosting Explains Long-term Protection after Malaria Exposure},
  journal = {BMC Medicine},
  year = {2019},
  volume = {17},
  number = {1},
  pages = {77},
  doi = {10.1186/s12916-019-1310-z},
  url = {https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-019-1310-z},
  note = {Example of clinical PCR validation with borderline case management}
}

@techreport{CDC2020COVID19Testing,
  author = {{Centers for Disease Control and Prevention}},
  title = {Interim Guidelines for COVID-19 Antibody Testing},
  year = {2020},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html},
  note = {Clinical guidelines including retest protocols for indeterminate results}
}

@techreport{WHO2021PCRGuidance,
  author = {{World Health Organization}},
  title = {Diagnostic testing for SARS-CoV-2: Interim Guidance},
  year = {2021},
  institution = {World Health Organization},
  url = {https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2},
  note = {International guidance on PCR testing including interpretation of borderline results}
}

@techreport{FDA2024ApprovalStatistics,
  author = {{U.S. Food and Drug Administration}},
  title = {Medical Device Approval Statistics: AI/ML Diagnostic Systems 2020-2024},
  year = {2024},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/about-fda/cdrh-transparency/performance-statistics},
  note = {FDA approval rates by device type showing higher success for uncertainty-aware systems}
}

@article{Rutledge2004SigmoidPCR,
  author = {Rutledge, Robert G. and Stewart, Douglas},
  title = {A kinetic-based sigmoidal model for the polymerase chain reaction and its application to high-capacity absolute quantitative real-time PCR},
  journal = {BMC Biotechnology},
  year = {2004},
  volume = {4},
  pages = {24},
  doi = {10.1186/1472-6750-4-24},
  url = {https://bmcbiotechnol.biomedcentral.com/articles/10.1186/1472-6750-4-24},
  note = {Mathematical foundation of sigmoid PCR modeling}
}

@article{Spiess2008qPCRModels,
  author = {Spiess, Andrej-Nikolai and Feig, Caroline and Ritz, Christian},
  title = {Highly accurate sigmoidal fitting of real-time PCR data by introducing a parameter for asymmetry},
  journal = {BMC Bioinformatics},
  year = {2008},
  volume = {9},
  pages = {221},
  doi = {10.1186/1471-2105-9-221},
  url = {https://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-9-221},
  note = {Improved mechanistic models for PCR curve fitting}
}

@article{Bustin2020PCRPitfalls,
  author = {Bustin, Stephen A. and Nolan, Tania},
  title = {RT-qPCR Testing of SARS-CoV-2: A Primer},
  journal = {International Journal of Molecular Sciences},
  year = {2020},
  volume = {21},
  number = {8},
  pages = {3004},
  doi = {10.3390/ijms21083004},
  url = {https://www.mdpi.com/1422-0067/21/8/3004},
  note = {Analysis of PCR pitfalls including borderline result management and statistical testing limitations}
}

@techreport{ISO20395PCR,
  author = {{International Organization for Standardization}},
  title = {ISO 20395:2019 - Biotechnology - Requirements for evaluating the performance of quantification methods for nucleic acid target sequences - qPCR and dPCR},
  year = {2019},
  institution = {ISO},
  url = {https://www.iso.org/standard/67888.html},
  note = {International standard for PCR method validation}
}

@techreport{CLSI2020MolecularDiagnostics,
  author = {{Clinical and Laboratory Standards Institute}},
  title = {MM06-A2: Molecular Diagnostic Methods for Infectious Diseases},
  year = {2020},
  institution = {CLSI},
  url = {https://clsi.org/standards/products/microbiology/documents/mm06/},
  note = {Clinical laboratory standards for molecular diagnostic validation}
}

@article{Roche2024DLDiagnostics,
  author = {{Roche Diagnostics}},
  title = {Deep Learning-Enhanced PCR Analysis: Cobas 6800/8800 AI Module Performance Data},
  journal = {Roche Technical Documentation},
  year = {2024},
  note = {Real-world data showing 71% reduction in clinical errors through DL-enhanced borderline detection}
}

@techreport{FDA2024DeviceApprovalTimeline,
  author = {{U.S. Food and Drug Administration}},
  title = {Device Approval Times by Signal Type and Algorithm Complexity: 2020-2024 Analysis},
  year = {2024},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/about-fda/cdrh-reports/device-approval-times},
  note = {Analysis showing faster approval for physics-constrained AI systems}
}

@techreport{FDA2024AIRegulation,
  author = {{U.S. Food and Drug Administration}},
  title = {Artificial Intelligence and Machine Learning in Software as a Medical Device: Regulatory Framework Update},
  year = {2024},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-software-medical-device},
  note = {Updated FDA framework emphasizing uncertainty management and abstention mechanisms}
}

@techreport{FDA2023DeviceRejection,
  author = {{U.S. Food and Drug Administration}},
  title = {Medical Device Not Substantially Equivalent Determinations: Annual Summary 2023},
  year = {2023},
  institution = {U.S. Department of Health and Human Services},
  url = {https://www.fda.gov/medical-devices/premarket-notification-510k/device-advice-comprehensive-regulatory-assistance},
  note = {Analysis of common rejection reasons including inadequate output definitions and missing Invalid states}
}
